Literature DB >> 8725264

Prevention of trauma-induced neurodegeneration in infant rat brain.

C Ikonomidou1, Y Qin, J Labruyere, C Kirby, J W Olney.   

Abstract

Recent evidence implicates the endogenous excitatory neurotransmitters, glutamate (Glu) and aspartate, in the pathophysiology of traumatic injury in the adult CNS, but it is not known whether similar excitotoxic mechanisms mediate traumatic injury in the immature CNS. Therefore, we developed a model of brain contusion injury in infant rats and used this model to study the nature and evolution of the acute cytopathologic changes and to evaluate the ability of Glu receptor antagonists to protect the immature brain against such changes. Seven-day-old rat pups were subjected to contusion injury and were killed 0, 0.5, 1, 2, 4, and 6 h later for histologic evaluation of the brain. Physical tearing of the dura and minor disruption of underlying brain tissue was noted at 0 h. At 30 min a discrete zone of neuronal necrosis began to appear at the border of the trauma site; this zone progressively expanded over a period of 4 h. The cytopathologic changes closely resembled the type of changes Glu is known to cause; these changes consisted of swollen dendrites, degenerating neurons with pyknotic nuclei and markedly swollen cytoplasm, and dark cells with vacuolated cytoplasm. The noncompetitive N-methyl-D-aspartate (NMDA) antagonist, dizocilpine maleate, when administered 30 min before or 1 h after trauma, significantly attenuated the lesion. The competitive NMDA antagonist, 3-((-2)-carboxypiperazine-4-yl)-propyl-1-phosphonate, was also neuroprotective. The alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate/kainate receptor antagonist 2,3-dihydro-6-nitro-7-sulfamoyl-benzo(f)quinoxaline did not significantly suppress the lesion when given as three treatments (30 mg/kg each) 30 min before plus 15 and 75 min after the insult. These findings suggest that traumatic injury in the infant rat brain is mediated by endogenous excitotoxins (Glu and aspartate) acting at NMDA receptors and can be substantially mitigated by timely treatment with NMDA receptor antagonists.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8725264     DOI: 10.1203/00006450-199606000-00015

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  13 in total

Review 1.  Is being plastic fantastic? Mechanisms of altered plasticity after developmental traumatic brain injury.

Authors:  Christopher C Giza; Mayumi L Prins
Journal:  Dev Neurosci       Date:  2006       Impact factor: 2.984

Review 2.  Diffusion-weighted imaging of acute excitotoxic brain injury.

Authors:  Toshio Moritani; Wendy R K Smoker; Yutaka Sato; Yuji Numaguchi; Per-Lennart A Westesson
Journal:  AJNR Am J Neuroradiol       Date:  2005-02       Impact factor: 3.825

3.  Spatiotemporal evolution of apoptotic neurodegeneration following traumatic injury to the developing rat brain.

Authors:  Philip V Bayly; Krikor T Dikranian; Erin E Black; Chainllie Young; Yue-Qin Qin; Joann Labruyere; John W Olney
Journal:  Brain Res       Date:  2006-07-05       Impact factor: 3.252

4.  Neonatal treatment with a competitive NMDA antagonist results in response-specific disruption of conditioned fear in preweanling rats.

Authors:  Pamela S Hunt
Journal:  Psychopharmacology (Berl)       Date:  2006-01-17       Impact factor: 4.530

5.  Glial cell responses in a murine multifactorial perinatal brain injury model.

Authors:  Miriam Domowicz; Natasha L Wadlington; Judith G Henry; Kasandra Diaz; Miranda J Munoz; Nancy B Schwartz
Journal:  Brain Res       Date:  2017-12-21       Impact factor: 3.252

Review 6.  Influence of alcohol on mortality in traumatic brain injury.

Authors:  Razvan C Opreanu; Donald Kuhn; Marc D Basson
Journal:  J Am Coll Surg       Date:  2010-06       Impact factor: 6.113

7.  Mild traumatic brain injury to the infant mouse causes robust white matter axonal degeneration which precedes apoptotic death of cortical and thalamic neurons.

Authors:  K Dikranian; R Cohen; C Mac Donald; Y Pan; D Brakefield; P Bayly; A Parsadanian
Journal:  Exp Neurol       Date:  2008-03-21       Impact factor: 5.330

Review 8.  Neuropathological and biochemical features of traumatic injury in the developing brain.

Authors:  Petra Bittigau; Marco Sifringer; Ursula Felderhoff-Mueser; Henrik H Hansen; Chrysanthy Ikonomidou
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

9.  Glutamate and GABA receptor dysfunction in the fetal alcohol syndrome.

Authors:  John W Olney; David F Wozniak; Vesna Jevtovic-Todorovic; Nuri B Farber; Petra Bittigau; Chrysanthy Ikonomidou
Journal:  Neurotox Res       Date:  2002-06       Impact factor: 3.911

Review 10.  Glutamate antagonists are neurotoxins for the developing brain.

Authors:  Angela M Kaindl; Chrysanthy Ikonomidou
Journal:  Neurotox Res       Date:  2007-04       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.